These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18634926)

  • 81. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth.
    Fei AL; Udin RD; Johnson R
    Pediatr Dent; 1991; 13(6):327-32. PubMed ID: 1843987
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars.
    Zealand CM; Briskie DM; Botero TM; Boynton JR; Hu JC
    Pediatr Dent; 2010; 32(5):393-9. PubMed ID: 21070705
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Biodentine
    El Meligy OAES; Alamoudi NM; Allazzam SM; El-Housseiny AAM
    BMC Oral Health; 2019 Jan; 19(1):3. PubMed ID: 30612569
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparison of the efficacy of articaine and prilocaine local anaesthesia for pulpotomy of maxillary and mandibular primary molars.
    Yilmaz Y; Eyuboglu O; Keles S
    Eur J Paediatr Dent; 2011 Jun; 12(2):117-22. PubMed ID: 21668284
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical, Radiographic and Histological Evaluation of Primary Teeth Pulpotomy Using MTA And Ferric Sulfate.
    Junqueira MA; Cunha NNO; Caixeta FF; Marques NCT; Oliveira TM; Moretti ABDS; Cosme-Silva L; Sakai VT
    Braz Dent J; 2018; 29(2):159-165. PubMed ID: 29898062
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mineral Trioxide Aggregate Partial Pulpotomy Versus Formocresol Pulpotomy: A Randomized, Split-Mouth, Controlled Clinical Trial with 24 Months Follow-Up.
    Nematollahi H; Noorollahian H; Bagherian A; Yarbakht M; Nematollahi S
    Pediatr Dent; 2018 May; 40(3):184-189. PubMed ID: 29793564
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Current trends in pulp therapy: a survey analyzing pulpotomy techniques taught in pediatric dental residency programs.
    Walker LA; Sanders BJ; Jones JE; Williamson CA; Dean JA; Legan JJ; Maupome G
    J Dent Child (Chic); 2013; 80(1):31-5. PubMed ID: 23595242
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Assessing the efficacy of Laser pulpotomy versus conventional pulpotomy in primary teeth: A systematic review and meta-analysis of clinical trials.
    Pandiyan R; Lehl GK; Kumar R; Sharma U; Jagachandiran VV
    Lasers Med Sci; 2024 Jul; 39(1):198. PubMed ID: 39073657
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A randomized controlled trial of ProRoot MTA, OrthoMTA and RetroMTA for pulpotomy in primary molars.
    Kang CM; Kim SH; Shin Y; Lee HS; Lee JH; Kim GT; Song JS
    Oral Dis; 2015 Sep; 21(6):785-91. PubMed ID: 25970794
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial.
    El Meligy OA; Allazzam S; Alamoudi NM
    Quintessence Int; 2016; 47(7):571-80. PubMed ID: 27175451
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Is there life after Buckley's Formocresol? Part I -- a narrative review of alternative interventions and materials.
    Srinivasan V; Patchett CL; Waterhouse PJ
    Int J Paediatr Dent; 2006 Mar; 16(2):117-27. PubMed ID: 16430526
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial.
    Asgary S; Eghbal MJ
    Acta Odontol Scand; 2013 Jan; 71(1):130-6. PubMed ID: 22339289
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Calcium hydroxide partial pulpotomy is an alternative to formocresol pulpotomy based on a 3-year randomized trial.
    Trairatvorakul C; Koothiratrakarn A
    Int J Paediatr Dent; 2012 Sep; 22(5):382-9. PubMed ID: 22211737
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Randomized Controlled Trial Comparing the Success of Mineral Trioxide Aggregate and Ferric Sulfate as Pulpotomy Medicaments for Primary Molars.
    Cordell S; Kratunova E; Marion I; Alrayyes S; Alapati SB
    J Dent Child (Chic); 2021 May; 88(2):120-128. PubMed ID: 34321144
    [No Abstract]   [Full Text] [Related]  

  • 95. Comparison of ferric sulfate, formocresol, and a combination of ferric sulfate/formocresol in primary tooth vital pulpotomies: a retrospective radiographic survey.
    Burnett S; Walker J
    ASDC J Dent Child; 2002; 69(1):44-8, 12. PubMed ID: 12119812
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggregate (MTA) for endodontic therapy in primary teeth?
    Anthonappa RP; King NM; Martens LC
    Int Endod J; 2013 Mar; 46(3):198-204. PubMed ID: 23136828
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Outcome of formocresol/ZOE sub-base pulpotomies utilizing alternative radiographic success criteria.
    Strange DM; Seale NS; Nunn ME; Strange M
    Pediatr Dent; 2001; 23(4):331-6. PubMed ID: 11572492
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mineral Trioxide Aggregate and Diluted Formocresol Pulpotomy: Prospective and Retrospective Study Outcomes.
    Ghoniem N; Vaidyanathan V; Zealand CM; Sushynski JM; Mettlach SM; Botero TM; Majewski RF; Boynton JR; Hu JC
    J Mich Dent Assoc; 2018 Apr; 100(4):40-65. PubMed ID: 30636813
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Long-term evaluation of primary teeth molar pulpotomies with Biodentine and MTA: a CONSORT randomized clinical trial.
    Vilella-Pastor S; Sáez S; Veloso A; Guinot-Jimeno F; Mercadé M
    Eur Arch Paediatr Dent; 2021 Aug; 22(4):685-692. PubMed ID: 33683572
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Formocresol should be abandoned.
    Lewis B
    Dent Today; 2010 May; 29(5):10, 12, 14. PubMed ID: 20506908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.